ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.